vanoxerine has been researched along with egtazic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Blom, P; Kox, WJ; Müller, J; Petzelt, C; Schmehl, W | 1 |
2 other study(ies) available for vanoxerine and egtazic acid
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Xenon prevents cellular damage in differentiated PC-12 cells exposed to hypoxia.
Topics: Analysis of Variance; Animals; Benzazepines; Calcium; Cells, Cultured; Chelating Agents; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Egtazic Acid; Embryo, Mammalian; Hypoxia; L-Lactate Dehydrogenase; Mesencephalon; Nerve Growth Factor; Neurons; Neuroprotective Agents; PC12 Cells; Piperazines; Rats; Sulpiride; Xenon | 2004 |